PBMWW
Psyence Biomedical Ltd. WarrantNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
1.68
52W High
$0.06
52W Low
$0.01
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Psyence Biomedical Ltd. Warrant
Psyence Biomedical Ltd. is a pioneering entity in the psychedelic biopharmaceutical sector, focused on advancing psilocybin-based therapies to address significant mental health disorders, including anxiety and depression. With a strong foundation in scientific rigor and regulatory adherence, the company is positioned to leverage its comprehensive intellectual property portfolio amidst the evolving landscape of public attitudes towards psychedelics. As the market for mental health treatments grows, Psyence is poised to lead in developing innovative therapeutic solutions that harness the recognized benefits of psychedelics in clinical applications.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-6.23M |
| Operating Margin | 0.00% |
| Return on Equity | -58.60% |
| Return on Assets | -31.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $7.39 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $2.61M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
—
HV 20-Day
—
HV 30-Day
—
HV 60-Day
—
HV Rank
—
Data last updated: 7/9/2026